Evidence map›Paper›PMID 38073728›Full record

ArticleAdvanced biomedical research2023

Evaluation of Insulin Resistance (HOMA-IR) for Patients with and without Thyroid Nodules: A Patient-Based Study.

Leila Moradi, Maryam Amir Ahmadi, Azim Moaatamedfar, Homeira Rashidi, Ferdos Zaman, Hamed Taheri

Open access · goldAbstract read
In one paragraph

Article in Advanced biomedical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Leila MoradiDepartment of Internal Medicine, School of Medicine, Ahvaz Jondi Shapour University of Medical Sciences, Ahvaz, Iran.
Maryam Amir AhmadiDepartment of Internal Medicine, School of Medicine, Ahvaz Jondi Shapour University of Medical Sciences, Ahvaz, Iran.
Azim MoaatamedfarDepartment of Radiology, School of Medicine, Ahvaz Jondi Shapour University of Medical Sciences, Ahvaz, Iran.
Homeira RashidiDepartment of Internal Medicine, School of Medicine, Ahvaz Jondi Shapour University of Medical Sciences, Ahvaz, Iran.
Ferdos ZamanDepartment of Internal Medicine, School of Medicine, Ahvaz Jondi Shapour University of Medical Sciences, Ahvaz, Iran.
Hamed TaheriDepartment of Anatomical, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Ahvaz Jundishapur University of Medical Sciences · IRArak University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The aim of this study was to assess the prevalence of insulin resistance (HOMA-IR) between patients with and without thyroid nodules. Materials and Methods: This case-control study was performed on 86 patients with normal Thyroid-stimulating hormone (TSH) level (0.5-4.5 mIU/L) with thyroid nodules, who referred to Imam Khomeini and Golestan Hospitals (Ahvaz, Iran). Furthermore, 43 nonnodule patients with normal TSH level and normal thyroid ultrasonography were recruited from the general population as control group. The insulin resistance was evaluated for them made and the HOMA-IR ≥2.5 was defined as insulin resistance. Results: The mean of HOMA-IR value was significantly higher in thyroid nodule patients compared to controls (3.02 ± 1.92 vs. 1.10 ± 1.55; Conclusions: Our study shows there is an association between insulin resistance and thyroid nodules. The patients with thyroid nodules have higher HOMA-IR value.

Indexed as

Insulin resistancemetabolic syndromethyroid nodules

Identifiers

PMID38073728
PMCPMC10699221
OpenAlexW4386337379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.